Patents by Inventor Miroslav Dudas

Miroslav Dudas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150152460
    Abstract: The present invention is in the fields of biotechnology and molecular biology. More particularly, the present invention relates to cloning or subcloning one or more nucleic acid molecules comprising one or more type IIs restriction enzyme recognition sites. The present invention also embodies cloning such nucleic acid molecules using recombinational cloning methods such as those employing recombination sites and recombination proteins. The present invention also relates to nucleic acid molecules (including RNA and iRNA), as well as proteins, expressed from host cells produced using the methods of the present invention.
    Type: Application
    Filed: December 8, 2014
    Publication date: June 4, 2015
    Inventors: JONATHAN CHESNUT, MIROSLAV DUDAS, ADAM HARRIS, LOUIS LEONG, KNUT MADDEN
  • Publication number: 20140170710
    Abstract: The present invention is in the fields of biotechnology and molecular biology. More particularly, the present invention relates to cloning or subcloning one or more nucleic acid molecules comprising one or more type IIs restriction enzyme recognition sites. The present invention also embodies cloning such nucleic acid molecules using recombinational cloning methods such as those employing recombination sites and recombination proteins. The present invention also relates to nucleic acid molecules (including RNA and iRNA), as well as proteins, expressed from host cells produced using the methods of the present invention.
    Type: Application
    Filed: January 29, 2014
    Publication date: June 19, 2014
    Applicant: Life Technologies Corporation
    Inventors: Jonathan CHESNUT, Miroslav Dudas, Adam Harris, Louis Leong, Knut Madden
  • Patent number: 8338091
    Abstract: The present invention is in the fields of biotechnology and molecular biology. More particularly, the present invention relates to cloning or subcloning one or more nucleic acid molecules comprising one or more type IIs restriction enzyme recognition sites. The present invention also embodies cloning such nucleic acid molecules using recombinational cloning methods such as those employing recombination sites and recombination proteins. The present invention also relates to nucleic acid molecules (including RNA and iRNA), as well as proteins, expressed from host cells produced using the methods of the present invention.
    Type: Grant
    Filed: February 21, 2012
    Date of Patent: December 25, 2012
    Assignee: Life Technologies Corporation
    Inventors: Jonathan Chesnut, Miroslav Dudas, Adam Harris, Louis Leong, Knut Madden
  • Publication number: 20120149069
    Abstract: The present invention is in the fields of biotechnology and molecular biology. More particularly, the present invention relates to cloning or subcloning one or more nucleic acid molecules comprising one or more type IIs restriction enzyme recognition sites. The present invention also embodies cloning such nucleic acid molecules using recombinational cloning methods such as those employing recombination sites and recombination proteins. The present invention also relates to nucleic acid molecules (including RNA and iRNA), as well as proteins, expressed from host cells produced using the methods of the present invention.
    Type: Application
    Filed: February 21, 2012
    Publication date: June 14, 2012
    Applicant: LIFE TECHNOLOGIES CORPORATION
    Inventors: Jonathan D. Chesnut, Knut R. Madden, Miroslav Dudas, Louis Leong, Adam N. Harris
  • Publication number: 20110046201
    Abstract: The present invention is in the fields of biotechnology and molecular biology. More particularly, the present invention relates to cloning or subcloning one or more nucleic acid molecules comprising one or more type IIs restriction enzyme recognition sites. The present invention also embodies cloning such nucleic acid molecules using recombinational cloning methods such as those employing recombination sites and recombination proteins. The present invention also relates to nucleic acid molecules (including RNA and iRNA), as well as proteins, expressed from host cells produced using the methods of the present invention.
    Type: Application
    Filed: April 30, 2008
    Publication date: February 24, 2011
    Applicant: INVITROGEN CORPORATION
    Inventors: Jonathan D. Chesnut, Knut R. Madden, Miroslav Dudas, Louis Leong, Adam N. Harris
  • Publication number: 20050069929
    Abstract: The present invention is in the fields of biotechnology and molecular biology. More particularly, the present invention relates to cloning or subcloning one or more nucleic acid molecules comprising one or more type IIs restriction enzyme recognition sites. The present invention also embodies cloning such nucleic acid molecules using recombinational cloning methods such as those employing recombination sites and recombination proteins. The present invention also relates to nucleic acid molecules (including RNA and iRNA), as well as proteins, expressed from host cells produced using the methods of the present invention.
    Type: Application
    Filed: August 9, 2004
    Publication date: March 31, 2005
    Applicant: Invitrogen Corporation
    Inventors: Jonathan Chestnut, Knut Madden, Miroslav Dudas, Louis Leong, Adam Harris